As of the current date (January 19, 2026), there has been no official, nationwide recall of prazosin issued by the U.S. Food and Drug Administration (FDA) or major pharmaceutical manufacturers in late 2025 or early 2026.
However, it’s important to clarify what may be causing confusion—and how to stay informed if a recall does occur.
🔍 What Is Prazosin?
Prazosin is a generic prescription medication (formerly sold under the brand name Minipress) used to treat:
High blood pressure
Benign prostatic hyperplasia (BPH)
PTSD-related nightmares (common off-label use)✅ No Class I, II, or III recalls of prazosin have been publicly announced by the FDA.
✅ No voluntary manufacturer-wide recalls from major generic producers (e.g., Teva, Mylan, Aurobindo, Zydus) are active.
⚠️ Isolated lot-level quality issues may occur (e.g., labeling errors, out-of-spec dissolution), but none have risen to the level of a public health alert.❓ Why Might You Hear About a “Recall”?
Confusion with other medications:
In 2023–2024, several blood pressure medications (like certain ARBs or diuretics) had recalls due to nitrosamine impurities—but prazosin was not among them.
Local pharmacy notices:
A single pharmacy might return a batch due to storage issues (e.g., temperature exposure), but this doesn’t constitute an official recall.
Misinformation online:
AI-generated or sensationalized content sometimes fabricates “recalls” to drive clicks.
✅ How to Verify a Recall (If You’re Concerned)
Check your prescription bottle: Note the NDC number, lot number, and manufacturer.
Search the FDA’s Recall Database:
→ https://www.fda.gov/safety/recalls
Visit the manufacturer’s website (e.g., Teva, Mylan).
Call your pharmacist—they receive real-time recall alerts.
